The Latest

During the past month, Fraud by the Numbers has explored the pervasive nature of fraud on the government and financial markets across sectors, and the efforts to fight that fr

Thus far, 2025 False Claims Act settlement activity is shaping up to be more active than the first three quarters of 2024.

In earlier Fraud by the Numbers, we have reviewed the U.S. Government’s own procurement data, to examine how taxpayer dollars are allocated across agencies and procurement

The Anti-Money Laundering Act (AMLA) of 2020 created a whistleblower reward program for individuals who report violations of the Bank Secrecy Act,

If you’ve worked for a company that holds federal contracts, especially in tech, healthcare, or defense, you might be surprised to learn that cybersecurity failures can be con

States are currently facing significant fiscal challenges, with tax revenues weakening through late 2024 and into fiscal year 2025.

Federal and state governments spend an enormous amount of their resources on prescription drugs.

Healthcare fraud generates the bulk of the Government’s recoveries under the False Claims Act (“FCA”).

The IRS Whistleblower Office published their annual fiscal year (“FY”) report for 2024.

Over the past decade, private equity (PE) firms have dramatically increased their presence in the U.S. economy.